Medications included in Noom GLP-1 Rx Program are produced in USP-compliant, state-regulated pharmacies but not reviewed by the FDA for safety, efficacy or quality
Standard titration protocols for Ozempic (diabetes indication) begin with 0.25 mg once weekly for four weeks, followed by an increase to 0.5 mg weekly
Current clinical trials data show that nausea, vomiting, diarrhea, constipation, fatigue, and headaches are common side effects of retatrutide
The evolving place of incretin-based therapies in type 2 diabetes
How can I relieve Ozempic-induced nausea
Tirzepatide: From Phase 3 to Pharmacy in 2.5 Years Eli Lilly started the SURMOUNT trial program for tirzepatide in late 2020